Skip to content
healthcare.dev

Glipizide

NDC 59651-780, Glipizide, tablet, extended release, from Aurobindo Pharma Limited.

Product NDC
59651-780
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206928
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-780 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE2.5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
59651-780-305965107803030 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-780-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/84794a52-b717-488c-8533-6425c83d405f
  • NADAC price for package 59651078030

    GET /v1/drugs/nadac/59651078030

Use it

Look up 59651-780 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-780 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-780. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.